Community Financial Services Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.2K Buy
423
+198
+88% +$26.8K 0.01% 212
2026
Q1
$28.9K Buy
+225
New +$28.1K 0.01% 222
2021
Q4
$709K Hold
6,339
0.18% 66
2021
Q3
$797K Sell
6,339
-4,450
-41% -$573K 0.22% 58
2021
Q2
$1.46M Sell
10,789
-726
-6% -$95.5K 0.41% 45
2021
Q1
$1.56M Sell
11,515
-946
-8% -$142K 0.46% 47
2020
Q4
$1.75M Sell
12,461
-1,716
-12% -$220K 0.55% 44
2020
Q3
$1.58M Sell
14,177
-7,630
-35% -$855K 0.58% 43
2020
Q2
$2.44M Sell
21,807
-64,677
-75% -$6.37M 0.93% 38
2020
Q1
$6.7M Buy
86,484
+2,367
+3% +$210K 2.28% 16
2019
Q4
$8M Buy
84,117
+2,641
+3% +$228K 2.08% 19
2019
Q3
$6.21M Buy
+81,476
New +$6.77M 1.8% 26

Other funds holding XBI

Community Financial Services Group's XBI Position: Q2 2026 in Review

Community Financial Services Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 88% in Q2 2026, buying an estimated $26.8K and bringing the position to 423 shares worth $66.2K. The position accounts for 0.01% of the portfolio, ranked #212.

Community Financial Services Group first reported a position in XBI in Q3 2019 and has held it in 12 quarters since. The position peaked at $8M in Q4 2019. 178 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Community Financial Services Group held 423 shares of State Street SPDR S&P Biotech ETF worth $66.2K as of Q2 2026.
  • Community Financial Services Group bought 198 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $26.8K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Community Financial Services Group's portfolio in Q2 2026, its #212 holding.
  • Community Financial Services Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 12 quarters since.
  • Community Financial Services Group's State Street SPDR S&P Biotech ETF position peaked at $8M in Q4 2019.
  • 178 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Community Financial Services Group's 13F filing for Q2 2026, filed 9 Jul 2026.